Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry.
about
The structural basis of arrestin-mediated regulation of G-protein-coupled receptorsAnalyzing the roles of multi-functional proteins in cells: The case of arrestins and GRKsStructure of an Arrestin2-Clathrin Complex Reveals a Novel Clathrin Binding Domain That Modulates Receptor TraffickingMechanism of substrate specificity in 5′-methylthioadenosine/S-adenosylhomocysteine nucleosidasesIdentification and characterization of EX1 kinetics in H/D exchange mass spectrometry by peak width analysis.Identification of receptor binding-induced conformational changes in non-visual arrestins.The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activationMonomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 bindingThe functional cycle of visual arrestins in photoreceptor cells.Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutantSerine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm.Critical role of the central 139-loop in stability and binding selectivity of arrestin-1.JNK3 enzyme binding to arrestin-3 differentially affects the recruitment of upstream mitogen-activated protein (MAP) kinase kinasesArrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking.Custom-designed proteins as novel therapeutic tools? The case of arrestins.Synthetic biology with surgical precision: targeted reengineering of signaling proteins.Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.Conformational insight into multi-protein signaling assemblies by hydrogen-deuterium exchange mass spectrometry.Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity.Functional characterization and conformational analysis of the Herpesvirus saimiri Tip-C484 protein.Targeting individual GPCRs with redesigned nonvisual arrestins.Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.Therapeutic potential of small molecules and engineered proteins.Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitinationArrestin-dependent activation of JNK family kinasesEnhanced phosphorylation-independent arrestins and gene therapy.
P2860
Q24657537-35A865BA-B3E2-4F91-96B7-236F031965F0Q26785358-FB010317-FEA8-4356-BDD1-5A85BA79D73EQ27657193-B5ABBED1-7CC1-4395-A2E6-EE73934E1B0EQ27662360-46BD4A35-D0CB-4CA0-B4D2-FFC31908B94EQ33252189-0B5982C3-D92B-4723-BB89-B6B723FD72E3Q33947214-A8746D6E-EA27-491F-9267-AF9D70A8E0B1Q34103312-9126DFD5-88D5-4D99-969C-F7828D248D82Q34489038-780EBD3A-0F4A-400A-9523-65E65D1C9D18Q35387361-02BFB1C9-415D-49F9-AA4D-DD0611E2299EQ36003914-09B49A62-D8C5-4F88-9F6F-31DB736EB1F8Q36451963-A405C7B0-2264-4AB9-A5B2-ACBA230B6797Q36726881-8397324E-EB62-45ED-9D65-413FF11EF279Q36796795-AEAA59E2-771B-4D95-9B39-B6DE3C5D693FQ37213763-E1528E49-86BB-4303-97AC-1525BCC9382EQ37415694-CC3B59DF-9CEC-4823-8B58-542A109ADF57Q37676928-5C4CC0A5-8C19-4998-8CA2-488B95DE968DQ37735949-BBF28229-4F55-4203-86FA-57AEB6C679CCQ38016028-386DFF80-3E19-4B69-BE04-F2D929520F12Q38716027-0CA91E59-51F1-4378-B0EB-AACAB841AAF3Q38934734-557E300B-5FA1-41DA-A29D-00A32A2A4260Q40159254-3B51383D-D4BB-4C86-92F2-FAF7A197F2ADQ41822040-F8508AA9-761C-45E7-826E-26FA6898000EQ41872788-B55CBE5A-9E99-42A4-AB8C-6369E4AC6F3BQ41981772-F280A08D-AA54-4730-BD8F-9ABDDE091016Q42098997-651F39D2-30D8-4413-B9E5-62F7028CD2D2Q42173591-AAA8A64C-771E-4AA6-8A67-4999FD5C5B1FQ42385786-CD765AD5-6119-4DC1-B27A-845BB49B6F49Q42394084-70346DE4-02DD-4F4A-A204-3CD9C9E8DAA0
P2860
Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Conformational differences bet ...... en exchange mass spectrometry.
@ast
Conformational differences bet ...... en exchange mass spectrometry.
@en
type
label
Conformational differences bet ...... en exchange mass spectrometry.
@ast
Conformational differences bet ...... en exchange mass spectrometry.
@en
prefLabel
Conformational differences bet ...... en exchange mass spectrometry.
@ast
Conformational differences bet ...... en exchange mass spectrometry.
@en
P50
P1476
Conformational differences bet ...... en exchange mass spectrometry.
@en
P2093
Jennifer M Carter
P304
P356
10.1016/J.JMB.2005.06.048
P407
P577
2005-08-01T00:00:00Z